DEPREV_Phase 2: Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption

Sponsor
University Hospital, Brest (Other)
Overall Status
Recruiting
CT.gov ID
NCT05125783
Collaborator
Ecole des Hautes Etudes en Santé Publique (Other)
600
3
12
200
16.7

Study Details

Study Description

Brief Summary

Alcohol use is the second leading cause of preventable death after smoking. The Evin law was built in 1991 with the goal of reducing exposure to alcohol marketing among the youngest. But this law is currently extremely weakened, and in a press release of February 26, 2018, the French Society of Alcoology is alarmed by these developments.

Studies on the impact of alcohol marketing focus for the most part on young adolescents and the links between marketing exposure and alcohol initiation. But beyond these links, little work has been done on the impact of alcohol marketing on vulnerable subjects with regular alcohol consumption. Alcohol consumption is one of the very first causes of hospitalization in France. The damage is often limited to the notion of risks of dependence, but it can appear as soon as consumption of 1 standard unit/day and mainly concerns the 45-64 year olds. To investigator knowledge, there are no studies on the impact of alcohol marketing carried out among regular alcohol users with moderate or severe alcohol use disorders.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire

Study Design

Study Type:
Observational
Anticipated Enrollment :
600 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Multifactorial Analysis of the Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption on the Perception of Alcohol Risks and According to Types of Use and Individual Vulnerabilities
Actual Study Start Date :
Feb 7, 2022
Anticipated Primary Completion Date :
Feb 7, 2023
Anticipated Study Completion Date :
Feb 7, 2023

Outcome Measures

Primary Outcome Measures

  1. Alcohol marketing strategies [1 day]

    Confirmation of alcohol marketing strategies significantly influencing alcohol risk perception alcohol cravings in patients with moderate to severe alcohol use disordersin a large population of people with alcohol use disorders seeking care.

Secondary Outcome Measures

  1. Alcohol craving [1 day]

    Self-assessment of craving measured by a visual analog scale from 0 (no craving for alcohol) to 10 (irrepressible craving for alcohol) relative to the question "How much do you estimate your craving for alcohol? "

  2. Alcohol consumption [Day 1]

    Ability to control one's drinking, as measured by a visual analog scale from 0 (no ability to control) to 10 (perceived total control over drinking) relative to the question "How much do you estimate your ability to control your own drinking?"

  3. Evaluation of severity of alcohol use disorders [Day 1]

    Severity of alcohol use disorders as measured by the number of DSM5 (Diagnostic and Statistical manual of Mental disorders 5) criteria. The DSM5 score is diagnosis of addiction is based on welldefined criteria set out in the Diagnostic and Statistical manual of Mental disorders (DSM), the fifth edition of which was published in 2013. The questionnaire consists of 11 items (diagnostic criteria for substance use disorders from the American Psychiatric Association's DSM V). The presence of 2 to 3 criteria: low addiction / Presence of 4 to 5 criteria : moderate addiction / Presence of 6 or more criteria: severe addiction.

  4. Evaluation of severity of alcohol use disorders [Day 1]

    Severity of alcohol use disorders as measured will be evaluated by Alcohol Use Disorders Identification Test (AUDIT) scale. AUDIT is a 10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems. A score of 8 or more is considered to indicate hazardous or harmful alcohol use.

  5. Socio-demographic characteristics [Day 1]

    The impact of marketing stimuli will be evaluated according to socio-demographic characteristics.

  6. Alcohol consumption [Day1]

    Assessment of the type of alcohol consumption

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patient over 18 years of age

  • Patient with moderate to severe alcohol use disorders (beyond 3 out of 11 criteria on the DSM-5 scale)

  • Non-opposition of the patient

Exclusion Criteria:
  • Minor patient

  • Patient who has already participated in phase 1 of the project

  • Non-comprehension of the written French language

  • Refusal to participate in the study

  • Patient of legal age, deprived of liberty by a judicial or administrative decision or unable to express their consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Morgane GUILLOU-LANDREAT Brest France 29609
2 Jean-Pierre SIMSON Brest France
3 Benoit SCHRECK Nantes France

Sponsors and Collaborators

  • University Hospital, Brest
  • Ecole des Hautes Etudes en Santé Publique

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT05125783
Other Study ID Numbers:
  • 29BRC21.0178 (DEPREV_Phase 2)
First Posted:
Nov 18, 2021
Last Update Posted:
Mar 2, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2022